Hair Loss on Weight Loss Injections: What's Actually Happening and What to Do
Noticing more hair in the shower since starting Mounjaro or Wegovy? Here's what's causing it, whether it's permanent, and how to reduce the risk.
Written and medically reviewed by:

Key Takeaways
Hair loss on Mounjaro or Wegovy is usually caused by rapid weight loss triggering telogen effluvium, not the drug itself. It's typically temporary and resolves within 6 months. Eating enough protein and key nutrients reduces the risk.
Is Hair Loss a Real Side Effect of GLP-1 Injections?#
If you've started Mounjaro, Wegovy, or another weight loss injection and noticed more hair coming out in the shower, you're not imagining it. Hair shedding is listed as a common adverse event in Mounjaro's patient information leaflet, affecting between 1 in 10 and 1 in 100 users. A 2022 clinical study found that 4.9 to 5.7% of patients on tirzepatide (Mounjaro) experienced hair loss, compared with just 0.9% in the placebo group.
But here's the important thing to understand: the medication itself isn't thought to be directly causing your hair to fall out. The trigger is almost certainly rapid weight loss, not the drug.
What's Actually Going On: Telogen Effluvium Explained#
The condition behind most GLP-1-related hair shedding is called telogen effluvium. It sounds alarming, but it's a well-understood, usually temporary response to physical stress on the body.
Normally, around 10% of your hair follicles are resting at any given time. These follicles are in the telogen (resting) phase of the hair growth cycle, while the others are actively growing. A major physiological stressor, whether that's childbirth, surgery, illness, or rapid weight loss, can push a much higher proportion of follicles into that resting phase at once. In someone with telogen effluvium, that figure can jump to around 30%.
The result is noticeably more shedding than usual. It's not that the follicles are dying; they've just temporarily paused. And because this shift happens across a large number of follicles simultaneously, the shedding tends to become obvious around 8 to 16 weeks after the triggering event.
When rapid calorie restriction is involved, nutritional deficiencies can make things worse. Iron, zinc, biotin, and protein are all essential for healthy hair growth. If your appetite is significantly reduced while taking a GLP-1 medication, it's easy to fall short of the nutrients your body needs to keep hair follicles functioning normally.
How Long Does It Last?#
For most people, telogen effluvium from weight loss is temporary and self-limiting. Once the trigger is resolved (weight stabilises, nutrition improves), hair growth typically returns to its normal cycle. Most people see regrowth within 3 to 6 months of the shedding peak.
The typical patient timeline looks something like this:
- Weeks 1 to 8: No noticeable hair change while starting or titrating dose
- Weeks 8 to 16: Shedding begins as follicles enter the resting phase en masse
- Weeks 16 to 20: Shedding often peaks around this point
- Months 4 to 6: Hair regrowth begins as the cycle normalises
- 6 to 12 months: Most people return to their baseline hair density
This timeline varies between individuals, and it can feel very unsettling in the middle of it. But clinically significant, permanent hair loss from telogen effluvium alone is rare.

Does It Happen More with Some Medications Than Others?#
Hair loss has been reported with all the major GLP-1 weight loss medications used in the UK, including Wegovy (semaglutide), Mounjaro (tirzepatide), Saxenda (liraglutide), and Ozempic (semaglutide, though not licensed for weight loss in the UK). The common thread is rapid weight loss rather than the specific drug involved.
That said, faster weight loss may increase the risk. Mounjaro and Wegovy tend to produce more significant weight loss than Saxenda, which could partly explain why hair shedding reports are more common with the newer agents. The rate at which you titrate your dose may also matter. Moving through the dose escalation schedule too quickly can amplify the physiological stress your body experiences.
Here's a rough comparison based on clinical trial data:
| Medication | Active ingredient | Hair loss incidence (clinical trials) |
|---|---|---|
| Mounjaro | Tirzepatide | 4.9 to 5.7% (vs 0.9% placebo) |
| Wegovy | Semaglutide | Reported; exact % varies by trial |
| Saxenda | Liraglutide | Lower reported rates; less total weight loss |
| Ozempic | Semaglutide | Reported in post-marketing data |
The incidence rates aren't always directly comparable because trials use different endpoints and follow-up periods, but the pattern is consistent: more weight lost more quickly tends to mean a greater risk of telogen effluvium.
How to Reduce the Risk of Hair Loss on GLP-1 Medications#
Don't Skip the Titration Schedule#
The dose escalation schedules for Mounjaro and Wegovy exist for good reasons. Starting at a lower dose and increasing gradually over several weeks gives your body time to adapt. Rushing through the titration phase increases GI side effects and may also increase the metabolic stress that contributes to hair shedding. If you're finding side effects difficult to manage, speak to your prescriber about slowing the titration.
Prioritise Protein and Micronutrients#
This is probably the most practical step you can take. A reduced appetite is one of the main mechanisms by which GLP-1 medications work, but eating less means you need to be more deliberate about nutritional quality, not less.
Focus on:
- Protein: Aim for at least 1.2g per kg of body weight per day. Protein supports muscle mass and is fundamental to hair growth. Eggs, lean meat, fish, Greek yoghurt, and legumes are practical sources.
- Iron: Deficiency is one of the most common triggers of telogen effluvium. Women of reproductive age are particularly at risk. Good sources include red meat, leafy greens, and fortified cereals.
- Zinc: Found in meat, shellfish, seeds, and wholegrains.
- Biotin: Widely discussed for hair health, though evidence for supplementation in people without deficiency is limited. Still, maintaining adequate levels makes sense if your diet is restricted.
If you're concerned about nutrient gaps, a blood test through your GP can check ferritin (stored iron), B12, folate, vitamin D, and thyroid function, all of which can contribute to hair loss independently of weight loss medication.
Consider Slowing Your Weight Loss Rate#
Very rapid weight loss is harder on the body than a more gradual approach. If you're losing more than 1 to 1.5kg per week consistently, this may increase your risk of telogen effluvium. Working with your clinician to aim for a steadier rate of loss can reduce physiological stress without undermining your progress.
What About Hair Loss Treatments?#
For most people experiencing telogen effluvium from weight loss, specific hair loss treatment isn't necessary because the shedding resolves once the trigger stabilises. However, if shedding is severe, persists beyond 6 months, or if you're experiencing additional androgenetic hair loss (male pattern baldness) on top of the telogen effluvium, treatment options are available.
For men, clinically proven options include finasteride and minoxidil. Finasteride is a once-daily tablet that blocks the conversion of testosterone to DHT, the hormone responsible for male pattern baldness. Minoxidil (including the Regaine brand) is applied topically to the scalp and stimulates hair regrowth.
If you're a man dealing with hair loss that goes beyond what you'd expect from temporary shedding, Totiva's hair loss service offers pharmacist-led consultations for finasteride and minoxidil, with no upfront cost until you're approved. Finasteride tablets start from £14.99 for 28 tablets, and Regaine liquid solution is available from £33.60.
It's worth noting that Totiva's hair loss treatments are currently available for men only. Women experiencing hair loss alongside weight loss medication should speak to their GP, who can investigate hormonal and nutritional causes and refer appropriately.
When to See Your GP#
Telogen effluvium is usually a watch-and-wait situation, but there are signs that warrant a GP appointment sooner rather than later:
- Shedding is severe (large clumps, visible bald patches)
- Hair loss hasn't started improving after 6 months
- You're also experiencing fatigue, cold sensitivity, or changes in your menstrual cycle (which could suggest thyroid problems or iron deficiency anaemia)
- Hair is thinning in a pattern typical of androgenetic alopecia rather than diffuse shedding
- You have a personal or family history of alopecia areata
Your GP can arrange blood tests to rule out underlying causes and refer you to a dermatologist if needed. In the UK, the Yellow Card scheme (run by the MHRA) allows patients to report suspected side effects from any medicine, including weight loss injections. Reporting through the Yellow Card scheme helps regulators monitor emerging safety signals, and it's worth doing if you experience side effects that concern you. You can submit a report at the MHRA Yellow Card website.

Got questions? Speak to a pharmacist on WhatsApp now
Prefer to browse first? View treatments
A Brief Note on Aquipta (Atogepant) and Hair Loss#
Some people searching about weight loss injection side effects also come across information about Aquipta (known as Qulipta in the US), a CGRP receptor antagonist used to prevent migraines in the UK. It's worth clarifying that Aquipta and GLP-1 weight loss injections are completely different drug classes, used for different conditions.
Aquipta (atogepant) is not associated with hair loss in its MHRA-approved UK Summary of Product Characteristics. The confirmed very common side effects of Aquipta are nausea and constipation, both of which are also seen with GLP-1 medications, which is likely why these queries get conflated. If you're on Aquipta for migraine prevention and experiencing hair shedding, it's far more likely to be related to another cause and worth discussing with your neurologist or GP.
Getting the Most Out of Your Weight Loss Treatment#
Hair shedding is a real and understandably worrying part of the GLP-1 experience for some people, but context matters. For the vast majority, it's temporary, resolves without specific treatment, and doesn't cause lasting hair loss. The key is going in prepared: eating well despite reduced appetite, titrating doses gradually, and knowing when to get things checked out.
If you're considering starting a weight loss injection like Mounjaro or Wegovy, Totiva's weight loss service offers pharmacist-led online consultations that include a video consultation before your first prescription, in line with UK regulatory requirements. You only pay once approved.
And if you're a man experiencing hair loss that seems to go beyond typical shedding, whether it's related to weight loss or not, it's worth exploring your options. You can start a free hair loss consultation with Totiva to find out whether finasteride or minoxidil might help.

Medical Information: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any treatment.


